| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 279.498 | 87 |
| GSM780708 | Untreated after 4 days (C2_1) | 267.3 | 86 |
| GSM780709 | Untreated after 4 days (C3_1) | 234.222 | 85 |
| GSM780719 | Untreated after 4 days (C1_2) | 277.373 | 87 |
| GSM780720 | Untreated after 4 days (C2_2) | 265.964 | 86 |
| GSM780721 | Untreated after 4 days (C3_2) | 216.866 | 84 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 358.785 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 280.805 | 87 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 546.534 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 331.003 | 88 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 278.021 | 87 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 594.322 | 93 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 276.516 | 87 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 300.107 | 87 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 281.543 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 283.236 | 87 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 293.605 | 87 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 257.24 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 279.046 | 87 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 238.754 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 272.048 | 87 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 252.832 | 86 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 271.799 | 87 |